相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triclosan Tolerance Is Driven by a Conserved Mechanism in Diverse Pseudomonas Species
Alexander G. McFarland et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2021)
Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection
Rachel Wheatley et al.
NATURE COMMUNICATIONS (2021)
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
Buqing Yi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies
R. Fredi Langendonk et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung
Quentin Menetrey et al.
GENES (2021)
New Sequence Type ST3449 in Multidrug-Resistant Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient
Catalina Diaz-Rios et al.
ANTIBIOTICS-BASEL (2021)
Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN
Arnaud Magallon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
The Transporter Classification Database (TCDB): 2021 update
Milton H. Saier et al.
NUCLEIC ACIDS RESEARCH (2021)
Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina
Mariana Papalia et al.
REVISTA ARGENTINA DE MICROBIOLOGIA (2020)
A case report of successful eradication of new isolates of Burkholderia cenocepacia in a child with cystic fibrosis
V Sputael et al.
ACTA CLINICA BELGICA (2020)
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry
Elpis Hatziagorou et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Achromobacter veterisilvae sp. nov., from a mixed hydrogen-oxidizing bacteria enrichment reactor for microbial protein production
Charles Dumolin et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2020)
Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors
Pitchaipillai Sankar Ganesh et al.
MICROBIOLOGY AND IMMUNOLOGY (2020)
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection
Gabriella Costabile et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia
Viola C. Scoffone et al.
TRENDS IN MICROBIOLOGY (2020)
The Microbiome in Cystic Fibrosis Pulmonary Disease
Alice Francoise et al.
GENES (2020)
Computational approaches in efflux pump inhibitors: current status and prospects
Ekta Rathi et al.
DRUG DISCOVERY TODAY (2020)
Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia
M. Biagi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Achromobacter Infections and Treatment Options
Burcu Isler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient
Andrew B. Gainey et al.
PEDIATRIC PULMONOLOGY (2020)
MexXY RND pump of Pseudomonas aeruginosa PA7 effluxes bi-anionic β-lactams carbenicillin and sulbenicillin when it partners with the outer membrane factor OprA but not with OprM
Manu Singh et al.
MICROBIOLOGY-SGM (2020)
Antibiotic export by MexB multidrug efflux transporter is allosterically controlled by a MexA-OprM chaperone-like complex
Marie Glavier et al.
NATURE COMMUNICATIONS (2020)
Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants
Eduarda Silva et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
Chandra L. Shrestha et al.
SCIENTIFIC REPORTS (2020)
AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand
Pisut Pongchaikul et al.
FEMS MICROBIOLOGY LETTERS (2020)
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation
Robert Lord et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
Vidya P. Narayanaswamy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
Vanessa E. Rees et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Comparative Genomic Analyses Reveal Core-Genome-Wide Genes Under Positive Selection and Major Regulatory Hubs in Outlier Strains of Pseudomonas aeruginosa
Utkarsh Sood et al.
FRONTIERS IN MICROBIOLOGY (2019)
Bioaccumulation and distribution of cadmium by Burkholderia cepacia GYP1 under oligotrophic condition and mechanism analysis at proteome level
Junhui Zhang et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2019)
Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia
Paula Blanco et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Overexpression of SmeGH contributes to the acquired MDR of Stenotrophomonas maltophilia
Li-Hua Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Target (MexB)- and Efflux-Based Mechanisms Decreasing the Effectiveness of the Efflux Pump Inhibitor D13-9001 in Pseudomonas aeruginosa PAO1: Uncovering a New Role for MexMN-OprM in Efflux of β-Lactams and a Novel Regulatory Circuit (MmnRS) Controlling MexMN Expression
Srijan Ranjitkar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Community analysis and co-occurrence patterns in airway microbial communities during health and disease
Gisli G. Einarsson et al.
ERJ OPEN RESEARCH (2019)
Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
Macha Tetart et al.
ERJ OPEN RESEARCH (2019)
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact
Jaroslav Nunvar et al.
ANTIBIOTICS-BASEL (2019)
0 Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of Achromobacter xylosoxidans
Signe M. Nielsen et al.
PATHOGENS (2019)
Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia
Paula Blanco et al.
SCIENTIFIC REPORTS (2019)
13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine
Kenta Kotani et al.
ANTIBIOTICS-BASEL (2019)
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Nicholas M. Maurice et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
Elizabeth B. Burgener et al.
CURRENT OPINION IN PEDIATRICS (2018)
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: insights into mechanism(s) of action
Elena Perrin et al.
FUTURE MICROBIOLOGY (2018)
Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia
Hye-Rim Kim et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung
Sebastian A. Riquelme et al.
JOURNAL OF INNATE IMMUNITY (2018)
RND transporters in the living world
Hiroshi Nikaido
RESEARCH IN MICROBIOLOGY (2018)
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans
Frank Fleurbaaij et al.
SCIENTIFIC REPORTS (2018)
Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens
Renee M. Fleeman et al.
FRONTIERS IN MICROBIOLOGY (2018)
Characterisation of OXA-258 enzymes and AxyABM efflux pump in Achromobacter ruhlandii
Mariana Papalia et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex
Lakshmi Vasireddy et al.
PLOS ONE (2018)
Role of the Multidrug Resistance Efflux Pump MexCD-OprJ in the Pseudomonas aeruginosa Quorum Sensing Response
Manuel Alcalde-Rico et al.
FRONTIERS IN MICROBIOLOGY (2018)
Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
Emmanuel Faure et al.
FRONTIERS IN IMMUNOLOGY (2018)
Role of smeU1VWU2X Operon in Alleviation of Oxidative Stresses and Occurrence of Sulfamethoxazole-TrimethoprimResistant Mutants in Stenotrophomonas maltophilia
Chao-Jung Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene
Michelle H. Prickett et al.
THORAX (2017)
Airway microbiota across age and disease spectrum in cystic fibrosis
Edith T. Zemanick et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
A Pan-Genomic Approach to Understand the Basis of Host Adaptation in Achromobacter
Julie Jeukens et al.
GENOME BIOLOGY AND EVOLUTION (2017)
Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study
B. D. Edwards et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
The evolution of lung transplantation for cystic fibrosis: A 2017 update
Gregory Snell et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia
So Young Chong et al.
MICROBIAL DRUG RESISTANCE (2017)
Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease
Sushma K. Cribbs et al.
TRANSLATIONAL RESEARCH (2017)
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
Emma Reece et al.
BMC PULMONARY MEDICINE (2017)
Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation
Jennifer Mesureur et al.
PLOS PATHOGENS (2017)
Double-Face Meets the Bacterial World: The Opportunistic Pathogen Stenotrophomonas maltophilia
Felipe Lira et al.
FRONTIERS IN MICROBIOLOGY (2017)
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
Viola C. Scoffone et al.
FRONTIERS IN MICROBIOLOGY (2017)
Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models
Freija Van den Driessche et al.
PLOS ONE (2017)
Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
Carla Lopez-Causape et al.
SCIENTIFIC REPORTS (2017)
Comparative genomics of a drug-resistant Pseudomonas aeruginosa panel and the challenges of antimicrobial resistance prediction from genomes
J. Jeukens et al.
FEMS MICROBIOLOGY LETTERS (2017)
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance
Elena Perrin et al.
BMC GENOMICS (2017)
Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin
Julien Bador et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Differences in Gene Expression Profiles between Early and Late Isolates in Monospecies Achromobacter Biofilm
Signe M. Nielsen et al.
PATHOGENS (2017)
Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients
Leonie Greipel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa
Ya-ping Pan et al.
ARCHIVES OF MICROBIOLOGY (2016)
Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
M. C. Firmida et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2016)
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
Hannah Y. Mahmood et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Antibiotic resistance in Burkholderia species
Katherine A. Rhodes et al.
DRUG RESISTANCE UPDATES (2016)
Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection
Siobhan McClean et al.
INFECTION AND IMMUNITY (2016)
Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran
Hamid Reza Goli et al.
INFECTION GENETICS AND EVOLUTION (2016)
Antibiotic and metal resistance in a ST395 Pseudomonas aeruginosa environmental isolate: A genomics approach
Pedro Teixeira et al.
MARINE POLLUTION BULLETIN (2016)
Novobiocin binding to NalD induces the expression of the MexAB-OprM pump in Pseudomonas aeruginosa
Weizhong Chen et al.
MOLECULAR MICROBIOLOGY (2016)
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Asher Brauner et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
Craig Winstanley et al.
TRENDS IN MICROBIOLOGY (2016)
Tripartite assembly of RND multidrug efflux pumps
Laetitia Daury et al.
NATURE COMMUNICATIONS (2016)
Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa
Yuji Morita et al.
FRONTIERS IN MICROBIOLOGY (2016)
Inactivation of SmeSyRy Two-Component Regulatory System Inversely Regulates the Expression of SmeYZ and SmeDEF Efflux Pumps in Stenotrophomonas maltophilia
Chao-Jung Wu et al.
PLOS ONE (2016)
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Benjamin K. Chan et al.
SCIENTIFIC REPORTS (2016)
The SmeYZ Efflux Pump of Stenotrophomonas maltophilia Contributes to Drug Resistance, Virulence-Related Characteristics, and Virulence in Mice
Yi-Tsung Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Intracellular survival of Burkholderia cepacia complex in phagocytic cells
Miguel A. Valvano
CANADIAN JOURNAL OF MICROBIOLOGY (2015)
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Xian-Zhi Li et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Comparative Genomics of Environmental and Clinical Stenotrophomonas maltophilia Strains with Different Antibiotic Resistance Profiles
Benjamin Youenou et al.
GENOME BIOLOGY AND EVOLUTION (2015)
Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies
Iain J. Abbott et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia
Viola C. Scoffone et al.
FRONTIERS IN MICROBIOLOGY (2015)
Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
Juerg Dreier et al.
FRONTIERS IN MICROBIOLOGY (2015)
Efflux pump-mediated drug resistance in Burkholderia
Nicole L. Podnecky et al.
FRONTIERS IN MICROBIOLOGY (2015)
Genomic Insights into Intrinsic and Acquired Drug Resistance Mechanisms in Achromobacter xylosoxidans
Yongfei Hu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis
Rasmus Lykke Marvig et al.
NATURE GENETICS (2015)
The problems of antibiotic resistance in cystic fibrosis and solutions
Carla Lopez-Causape et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)
SmeOP-TolCSm Efflux Pump Contributes to the Multidrug Resistance of Stenotrophomonas maltophilia
Cheng-Wen Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Mechanism of Resistance to an Antitubercular 2-Thiopyridine Derivative That Is Also Active against Burkholderia cenocepacia
Viola C. Scoffone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Differential Roles of RND Efflux Pumps in Antimicrobial Drug Resistance of Sessile and Planktonic Burkholderia cenocepacia Cells
Silvia Buroni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Structure of the AcrAB-TolC multidrug efflux pump
Dijun Du et al.
NATURE (2014)
The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity
Sung-Pin Tseng et al.
PLOS ONE (2014)
A Linkage between SmeIJK Efflux Pump, Cell Envelope Integrity, and σE-Mediated Envelope Stress Response in Stenotrophomonas maltophilia
Yi-Wei Huang et al.
PLOS ONE (2014)
Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
Cesar de la Fuente-Nunez et al.
PLOS PATHOGENS (2014)
Outbreak of Achromobacter xylosoxidans in an italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains
Maria Trancassini et al.
FRONTIERS IN MICROBIOLOGY (2014)
Coordinate Hyperproduction of SmeZ and SmeJK Efflux Pumps Extends Drug Resistance in Stenotrophomonas maltophilia
Virginia C. Gould et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump
Julien Bador et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle
Xiangyang Li et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Clinical relevance of the ESKAPE pathogens
Jack N. Pendleton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
A census of RND superfamily proteins in the Burkholderia genus
Elena Perrin et al.
FUTURE MICROBIOLOGY (2013)
Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data
Lucie Amoureux et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Structural basis for the inhibition of bacterial multidrug exporters
Ryosuke Nakashima et al.
NATURE (2013)
Characterization of pbt genes conferring increased Pb2+ and Cd2+ tolerance upon Achromobacter xylosoxidans A8
Katerina Hlozkova et al.
RESEARCH IN MICROBIOLOGY (2013)
Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics
Saira Khan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Joanna S. Brooke
CLINICAL MICROBIOLOGY REVIEWS (2012)
Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7
Yuji Morita et al.
MICROBIOLOGY-SGM (2012)
First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM
Julien Bador et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Contribution of Resistance-Nodulation-Division Efflux Pump Operon smeU1-V-W-U2-X to Multidrug Resistance of Stenotrophomonas maltophilia
Chao-Hsien Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms
Tom Coenye et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia
Silvia Bazzini et al.
PLOS ONE (2011)
Genomic Expression Analysis Reveals Strategies of Burkholderia cenocepacia to Adapt to Cystic Fibrosis Patients' Airways and Antimicrobial Therapy
Nuno P. Mira et al.
PLOS ONE (2011)
Pseudomonas aeruginosa: all roads lead to resistance
Elena B. M. Breidenstein et al.
TRENDS IN MICROBIOLOGY (2011)
The Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in Stenotrophomonas maltophilia
Alvaro Hernandez et al.
PLOS PATHOGENS (2011)
Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genonne-wide expression alterations
Carla P. Coutinho et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2011)
Pseudomonas aeruginosa genomic structure and diversity
Jens Klockgether et al.
FRONTIERS IN MICROBIOLOGY (2011)
Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species
Jorge H. Leitao et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Exploring the HME and HAE1 efflux systems in the genus Burkholderia
Elena Perrin et al.
BMC EVOLUTIONARY BIOLOGY (2010)
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence
P. Drevinek et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
The Changing Microbial Epidemiology in Cystic Fibrosis
John J. LiPuma
CLINICAL MICROBIOLOGY REVIEWS (2010)
Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance
Cecilia Andresen et al.
PROTEIN SCIENCE (2010)
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance
Silvia Buroni et al.
BMC MICROBIOLOGY (2009)
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Philip D. Lister et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria
Elke Peeters et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Biocide susceptibility of the Burkholderia cepacia complex
Helen Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients
Matthew T. G. Holden et al.
JOURNAL OF BACTERIOLOGY (2009)
Characterization of a naturally occurring class D β-lactamase from Achromobacter xylosoxidans
Yohei Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
MexCD-OprJ Multidrug Efflux System of Pseudomonas aeruginosa: Involvement in Chlorhexidine Resistance and Induction by Membrane-Damaging Agents Dependent upon the AlgU Stress Response Sigma Factor
Sebastien Fraud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Dynamics of Pseudomonas aeruginosa genome evolution
Kalai Mathee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants
Lisa C. Crossman et al.
GENOME BIOLOGY (2008)
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa.: Part 7:: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate
Ken-ichi Yoshida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Resistance mechanisms of multiresistant pseudomonas aeruginosa strains from Germany and correlation with Hypermutationdel
B. Henrichfreise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease
Silke Besier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome
Paola Guglierame et al.
BMC MICROBIOLOGY (2006)
Mechanisms of antimicrobial resistance in bacteria
Fred C. Tenover
AMERICAN JOURNAL OF MEDICINE (2006)
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Eric E. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa
D Hocquet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use
O Lomovskaya et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
ZH Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa
ML Sobel et al.
JOURNAL OF BACTERIOLOGY (2005)
The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump
P Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Aminoglycoside resistance in Pseudomonas aeruginosa
K Poole
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis
C Vogne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa:: Identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB
D Nehme et al.
JOURNAL OF BACTERIOLOGY (2004)
Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously
C Llanes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Antimicrobial resistance of Pseudomonas aeruginosa biofilms
E Drenkard
MICROBES AND INFECTION (2003)
Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa
Y Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa
TE Renau et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
S Häussler et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan
R Chuanchuen et al.
JOURNAL OF BACTERIOLOGY (2002)
SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia
XZ Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia
L Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa:: Identification of MexR binding sites in the mexA-mexR intergenic region
K Evans et al.
JOURNAL OF BACTERIOLOGY (2001)
Mechanisms of biofilm resistance to antimicrobial agents
TFC Mah et al.
TRENDS IN MICROBIOLOGY (2001)
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance
MD Lee et al.
FARMACO (2001)
Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia
A Alonso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
REW Hancock et al.
DRUG RESISTANCE UPDATES (2000)
Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa
H Maseda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
